Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3-glcglc-20-glcglc-ginsenoside
2. Arasaponin E1
3. Ginsenoside-rb1
4. Gynosaponin C
5. Gypenoside Iii
6. Notoginsenoside Rb1
7. Panax Saponin E
8. Panaxoside Rb1
9. Pseudoginsenoside D
10. Sanchinoside E1
11. Sanchinoside Rb1
1. Gynosaponin C
2. 41753-43-9
3. Gypenoside Iii
4. Sanchinoside E1
5. Arasaponin E1
6. Panax Saponin E
7. Pseudoginsenoside D
8. Ginsenoside-rb1
9. Panaxsaponin E
10. (20s)-ginsenoside Rb1
11. Chembl501515
12. Grb 1
13. Chebi:67989
14. Sanchinoside Rb1
15. 7413s0wmh6
16. Notoginsenoside Rb1
17. 2-o-beta-glucopyranosyl-(3beta,12beta)-20-[(6-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl Beta-d-glucopyranoside
18. Ginsenosiderb1
19. Einecs 255-532-8
20. Mfcd00133367
21. Panaxoside Rb1
22. 2-o-beta-glucopyranosyl-(3beta,12beta)-20-((6-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl)oxy)-12-hydroxydammar-24-en-3-yl-beta-d-glucopyranoside
23. Unii-7413s0wmh6
24. Gypenoside Cento
25. Nsc-310103
26. Nsc 310103
27. Gsrb1
28. Gs-rb1
29. 20(s)-ginsenoside Rb1
30. Ginsenoside Rb1 - 94%
31. Bidd:er0108
32. Ginsenoside Rb1 [usp-rs]
33. Ginsenoside Rb1 [who-dd]
34. Dtxsid401316929
35. Hms3885o12
36. Ex-a6786
37. Hy-n0039
38. Bdbm50317541
39. S3924
40. Akos025311537
41. Ccg-270640
42. Cs-3829
43. Db06749
44. Ncgc00347398-04
45. Bs-32417
46. Xg164977
47. N1620
48. C20713
49. 753g439
50. Q-100470
51. Ginsenoside Rb1, Primary Pharmaceutical Reference Standard
52. Ginsenoside Rb1, European Pharmacopoeia (ep) Reference Standard
53. Ginsenoside-rb1 From Panax Ginseng (korean Ginseng) Root, Triterpenoid Saponin
54. (3beta,12beta)-20-[(6-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl 2-o-beta-d-glucopyranosyl-beta-d-glucopyranoside
55. (3beta,12beta)-20-{[6-o-(beta-d-glucopyranosyl)-beta-d-glucopyranosyl]oxy}-12-hydroxydammar-24-en-3-yl 2-o-beta-d-glucopyranosyl-beta-d-glucopyranoside
56. .beta.-d-glucopyranoside, (3.beta.,12.beta.)-20-((6-o-.beta.-d-glucopyranosyl-.beta.-d-glucopyranosyl)oxy)-12-hydroxydammar-24-en-3-yl 2-o-.beta.-d-glucopyranosyl-
57. 3beta-[beta-d-glucopyranosyl-(1->2)-beta-d Glucopyranosyloxy]-20-[beta-d-glucopyranosyl-(1->2)-beta-d Glucopyranosyloxy]dammar-24-en-12beta-ol
58. Beta-d-glucopyranoside, (3-beta,12-beta)-20-((6-o-beta-d-glucopyranosyl-beta-d-glucopyranosyl)oxy)-12-hydroxydammar-24-en-3-yl 2-o-beta-d-glucopyranosyl-
59. Ginsenoside Rb1 (constituent Of American Ginseng, Asian Ginseng, And Tienchi Ginseng) [dsc]
Molecular Weight | 1109.3 g/mol |
---|---|
Molecular Formula | C54H92O23 |
XLogP3 | 0.3 |
Hydrogen Bond Donor Count | 15 |
Hydrogen Bond Acceptor Count | 23 |
Rotatable Bond Count | 16 |
Exact Mass | 1108.60293918 g/mol |
Monoisotopic Mass | 1108.60293918 g/mol |
Topological Polar Surface Area | 377 Ų |
Heavy Atom Count | 77 |
Formal Charge | 0 |
Complexity | 2000 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 30 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Ginsenoside Rb1 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ginsenoside Rb1, including repackagers and relabelers. The FDA regulates Ginsenoside Rb1 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ginsenoside Rb1 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ginsenoside Rb1 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ginsenoside Rb1 supplier is an individual or a company that provides Ginsenoside Rb1 active pharmaceutical ingredient (API) or Ginsenoside Rb1 finished formulations upon request. The Ginsenoside Rb1 suppliers may include Ginsenoside Rb1 API manufacturers, exporters, distributors and traders.
click here to find a list of Ginsenoside Rb1 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Ginsenoside Rb1 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ginsenoside Rb1 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ginsenoside Rb1 GMP manufacturer or Ginsenoside Rb1 GMP API supplier for your needs.
A Ginsenoside Rb1 CoA (Certificate of Analysis) is a formal document that attests to Ginsenoside Rb1's compliance with Ginsenoside Rb1 specifications and serves as a tool for batch-level quality control.
Ginsenoside Rb1 CoA mostly includes findings from lab analyses of a specific batch. For each Ginsenoside Rb1 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ginsenoside Rb1 may be tested according to a variety of international standards, such as European Pharmacopoeia (Ginsenoside Rb1 EP), Ginsenoside Rb1 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ginsenoside Rb1 USP).
LOOKING FOR A SUPPLIER?